NVNO

NVNO

USD

enVVeno Medical Corporation Common Stock

$2.735-0.031 (-1.121%)

即時價格

Healthcare
醫療器材
美國

價格圖表

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$2.766

最高

$2.766

最低

$2.660

交易量

0.00M

公司基本面

市值

48.0M

行業

醫療器材

國家

United States

交易統計

平均交易量

0.09M

交易所

NCM

貨幣

USD

52週範圍

最低 $2.028當前 $2.735最高 $6.48

相關新聞

AccessWire

Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand

- Access video webcasts from the first wave of participating companies hereFRENCHTOWN, NJ / ACCESS Newswire / February 19, 2025 / JTC Team , a fully integrated corporate communications and investor

查看更多
Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand
AccessWire

One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum

One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life indicators.PMA application for the VenoValve submitted in November 2024, with an FDA decision expected in the

查看更多
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
AccessWire

Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a clinically meaningful

查看更多
Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting